Race against time: new shot aims to save heart attack patients before hospital
Disease control
Ongoing
This large, late-stage study is testing if a single injection given by paramedics in the ambulance can improve survival and recovery for people having a major heart attack (STEMI). Over 2,400 patients will receive either the experimental drug zalunfiban or a placebo shot, with re…
Phase: PHASE3 • Sponsor: CeleCor Therapeutics • Aim: Disease control
Last updated Mar 02, 2026 15:23 UTC